factor

(redirected from factor VIII)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to factor VIII: Factor VIII deficiency

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
References in periodicals archive ?
Octocog alfa, human coagulation factor VIII or antihemophilic factor, is the active substance in KogenateA FS (KogenateA Bayer in Europe), which is approved in more than 90 countries worldwide.
People with haemophilia A are deficient in a key protein - factor VIII - which is vital in the clotting mechanism to prevent bleeding.
Two concentration levels of liposome with the same dose of factor VIII were evaluated; at the higher liposome concentration, patients treated with BAY 79-4980 went an average of 13.
Lot 10 - Coagulation Factor VIII von Willebrand factor plasma + 1000 IU / fl.
The current standard treatment for severe hemophilia A is regularly scheduled prophylactic infusion of factor VIII to keep factor VIII levels high enough to prevent bleeding.
Retrospective patient reviews have suggested that regular infusions of factor VIII given to prevent bleeding episodes may reduce the development of hemophilic arthropathy when initiated in young patients prior to the onset of permanent joint damage.
A tolerized and de-immunizedversion of factor VIII would allow patients and their families to experience the benefits of FVIII treatment, which does not induce a reaction of the immune system (no immunogenicity) without the fear of developing inhibitory antibodies ("inhibitors") against the therapeutic factor VIII.
Evaluation of user preference for a needleless factor VIII delivery device for haemophilia patients, Journal of Outcomes Research 2004; 8:63-78.
Gareth, like thousands of other haemophiliacs in Britain, is dependent on a blood product known simply as Factor VIII to ensure his blood is able to clot normally.
Though thrombotic events have been commonly reported with factor XI and factor VIII concentrates, it is an unusual complication after administration of DDAVP alone in a patient with VWD.
A safe, synthetic product - Recombinant Factor VIII - has been available for almost a decade, but its high cost means it is only available to under-16s on the NHS.
Therapy consists of periodic plasma-derived or recombinant factor VIII replacement.